STRADB expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.264800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.767200E-01
Normal-vs-Stage2
6.704900E-03
Normal-vs-Stage3
3.192200E-02
Normal-vs-Stage4
6.975700E-02
Stage1-vs-Stage2
2.004000E-01
Stage1-vs-Stage3
1.514800E-01
Stage1-vs-Stage4
3.686800E-01
Stage2-vs-Stage3
1.062430E-01
Stage2-vs-Stage4
5.928200E-01
Stage3-vs-Stage4
2.406400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.696300E-03
Normal-vs-AfricanAmerican
4.501800E-01
Normal-vs-Asian
1.668010E-02
Caucasian-vs-AfricanAmerican
5.814100E-02
Caucasian-vs-Asian
7.707400E-01
AfricanAmerican-vs-Asian
1.335200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.422300E-03
Normal-vs-Female
1.677920E-02
Male-vs-Female
3.500400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.476220E-01
Normal-vs-Age(41-60Yrs)
3.481800E-02
Normal-vs-Age(61-80Yrs)
1.501380E-03
Normal-vs-Age(81-100Yrs)
7.043700E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.811000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.304800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.165600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.276500E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.502200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.073000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.021400E-03
Normal-vs-Daily Drinker
7.275700E-03
Normal-vs-Weekly Drinker
9.940200E-02
Normal-vs-Occasional Drinker
2.301600E-03
Normal-vs-Social Drinker
2.692400E-01
Non Drinker-vs-Daily Drinker
6.878800E-01
Non Drinker-vs-Weekly Drinker
1.179960E-01
Non Drinker-vs-Occasional Drinker
6.375600E-01
Non Drinker-vs-Social Drinker
4.010300E-02
Daily Drinker-vs-Weekly Drinker
8.283600E-02
Daily Drinker-vs-Occasional Drinker
9.577200E-01
Daily Drinker-vs-Social Drinker
2.713900E-02
Weekly Drinker-vs-Occasional Drinker
5.752400E-02
Weekly Drinker-vs-Social Drinker
8.605000E-01
Occasional Drinker-vs-Social Drinker
1.552460E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.219600E-01
Normal-vs-Grade 2
9.148600E-01
Normal-vs-Grade 3
9.489000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.977800E-01
Grade 1-vs-Grade 3
6.449800E-01
Grade 1-vs-Grade 4
9.219600E-01
Grade 2-vs-Grade 3
4.460200E-01
Grade 2-vs-Grade 4
9.148600E-01
Grade 3-vs-Grade 4
9.489000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.566200E-04
Normal-vs-NonDiabetic
2.098500E-03
Diabetic-vs-NonDiabetic
1.192560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.471900E-02
Normal-vs-NoPancreatitis
1.024800E-03
Pancreatitis-vs-NoPancreatitis
6.904600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.559790E-02
Normal-vs-N1
4.317300E-03
N0-vs-N1
6.019000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.759800E-03
Normal-vs-TP53-NonMutant
3.984200E-02
TP53-Mutant-vs-TP53-NonMutant
5.688200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
